BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestry

被引：29

作者：

Friebel, Tara M. ^{[1
,2
]}

Andrulis, Irene L. ^{[3
,4
]}

Balmana, Judith ^{[5
]}

Blanco, Amie M. ^{[6
]}

Couch, Fergus J. ^{[7
]}

Daly, Mary B. ^{[8
]}

Domchek, Susan M. ^{[9
]}

Easton, Douglas F. ^{[10
,11
]}

Foulkes, William D. ^{[12
,13
]}

Ganz, Patricia A. ^{[14
,15
]}

Garber, Judy ^{[16
]}

Glendon, Gord ^{[3
]}

Greene, Mark H. ^{[17
]}

Hulick, Peter J. ^{[18
,19
]}

Isaacs, Claudine ^{[20
]}

Jankowitz, Rachel C. ^{[21
]}

Karlan, Beth Y. ^{[22
]}

Kirk, Judy ^{[23
]}

Kwong, Ava ^{[24
,25
,26
]}

Lee, Annette ^{[27
]}

Lesueur, Fabienne ^{[28
,29
,30
,31
]}

Lu, Karen H. ^{[32
,33
]}

Nathanson, Katherine L. ^{[9
]}

Neuhausen, Susan L. ^{[34
]}

Offit, Kenneth ^{[35
,36
]}

Palmero, Edenir I. ^{[37
,38
]}

Sharma, Priyanka ^{[39
]}

Tischkowitz, Marc ^{[12
,13
,40
]}

Toland, Amanda E. ^{[41
]}

Tung, Nadine ^{[42
]}

van Rensburg, Elizabeth J. ^{[43
]}

Vega, Ana ^{[44
,45
,46
]}

Weitzel, Jeffrey N. ^{[47
]}

Hoskins, Kent F. ^{[48
]}

Maga, Tara ^{[48
]}

Parsons, Michael T. ^{[49
]}

McGuffog, Lesley ^{[11
]}

Antoniou, Antonis C. ^{[11
]}

Chenevix-Trench, Georgia ^{[49
]}

Huo, Dezheng ^{[50
]}

Olopade, Olufunmilayo I. ^{[50
]}

Rebbeck, Timothy R. ^{[1
,2
]}

机构：

[1] Harvard TH Chan Sch Publ Hlth, Boston, MA USA

[2] Dana Farber Canc Inst, 1101 Dana Bldg,450 Brookline Ave, Boston, MA 02215 USA

[3] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Fred A Litwin Ctr Canc Genet, Toronto, ON, Canada

[4] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada

[5] Univ Hosp Vall dHebron, Vall dHebron Inst Oncol, High Risk & Canc Prevent Grp, Barcelona, Spain

[6] Univ Calif San Francisco, Canc Genet & Prevent Program, San Francisco, CA 94143 USA

[7] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA

[8] Fox Chase Canc Ctr, Dept Clin Genet, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[9] Univ Penn, Dept Med, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA

[10] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Oncol, Cambridge, England

[11] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge, England

[12] McGill Univ, Program Canc Genet, Dept Human Genet, Montreal, PQ, Canada

[13] McGill Univ, Program Canc Genet, Dept Oncol, Montreal, PQ, Canada

[14] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Sch Med, Div Canc Prevent & Control Res, Los Angeles, CA 90024 USA

[15] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Sch Publ Hlth, Div Canc Prevent & Control Res, Los Angeles, CA 90024 USA

[16] Dana Farber Canc Inst, Canc Risk & Prevent Clin, Boston, MA 02115 USA

[17] NCI, Div Canc Epidemiol & Genet, Clin Genet Branch, Bethesda, MD 20892 USA

[18] NorthShore Univ HealthSyst, Ctr Med Genet, Evanston, IL USA

[19] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA

[20] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA

[21] Univ Pittsburgh, Sch Med, Dept Med, Div Hematol Oncol,UPMC,Hillman Canc Ctr, Pittsburgh, PA 15213 USA

[22] Cedars Sinai Med Ctr, Womens Canc Program, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA

[23] Weatmead Hosp, Familial Canc Serv, Wentworthville, NSW, Australia

[24] Hong Kong Hereditary Breast Canc Family Registry, Canc Genet Ctr, Happy Valley, Hong Kong, Peoples R China

[25] Univ Hong Kong, Dept Surg, Pok Fu Lam, Hong Kong, Peoples R China

[26] Hong Kong Sanat & Hosp, Dept Surg, Happy Valley, Hong Kong, Peoples R China

[27] Feinstein Inst Med Res, Manhasset, NY USA

[28] INSERM, Genet Epidemiol Canc Team, Paris, France

[29] Inst Curie, Serv Genet, Paris, France

[30] Inst Curie, Paris, France

[31] Mines ParisTech, Fontainebleau, France

[32] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA

[33] Univ Texas MD Anderson Canc Ctr, Clin Canc Genet Program, Houston, TX 77030 USA

[34] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA USA

[35] Mem Sloan Kettering Canc Ctr, Clin Genet Res Lab, Dept Canc Biol & Genet, 1275 York Ave, New York, NY 10021 USA

[36] Mem Sloan Kettering Canc Ctr, Dept Med, Clin Genet Serv, 1275 York Ave, New York, NY 10021 USA

[37] Barretos Canc Hosp, Mol Oncol Res Ctr, Sao Paulo, Brazil

[38] Dr Paulo Prata FACISB, Barretos Sch Hlth Sci, Sao Paulo, Brazil

[39] Univ Kansas, Med Ctr, Dept Internal Med, Div Oncol, Westwood, KS USA

[40] Univ Cambridge, Addenbrookes Hosp, Addenbrookes Treatment Ctr, Dept Med Genet, Cambridge, England

[41] Ohio State Univ, Dept Canc Biol & Genet, Columbus, OH 43210 USA

[42] Beth Israel Deaconess Med Ctr, Dept Med Oncol, Boston, MA 02215 USA

[43] Univ Pretoria, Dept Genet, Arcadia, South Africa

[44] Fdn Publ Galega Med Xen, Santiago De Compostela, Spain

[45] Inst Invest Sanitaria Santiago de Compostela, Santiago De Compostela, Spain

[46] Biomed Network Rare Dis CIBERER, Madrid, Spain

[47] City Hope Natl Med Ctr, Clin Canc Genet, Duarte, CA USA

[48] Univ Illinois, Dept Med, Chicago, IL USA

[49] QIMR Berghofer Med Res Inst, Dept Genet & Computat Biol, Brisbane, Qld, Australia

[50] Univ Chicago, Ctr Clin Canc Genet, Chicago, IL 60637 USA

来源：

HUMAN MUTATION | 2019年 / 40卷 / 10期

基金：

加拿大健康研究院; 美国国家卫生研究院;

关键词：

African ancestry; BRCA1; BRCA2; mutation; pathogenic sequence variant; BREAST-CANCER PATIENTS; EARLY-ONSET BREAST; AMERICAN FAMILIES; MUTATION CARRIERS; OVARIAN-CANCER; PROPHYLACTIC OOPHORECTOMY; SALPINGO-OOPHORECTOMY; HEREDITARY BREAST; FOUNDER MUTATION; RISK REDUCTION;

D O I：

10.1002/humu.23804

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

BRCA1 and BRCA2 (BRCA1/2) pathogenic sequence variants (PSVs) confer elevated risks of multiple cancers. However, most BRCA1/2 PSVs reports focus on European ancestry individuals. Knowledge of the PSV distribution in African descent individuals is poorly understood. We undertook a systematic review of the published literature and publicly available databases reporting BRCA1/2 PSVs also accessed the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) database to identify African or African descent individuals. Using these data, we inferred which of the BRCA PSVs were likely to be of African continental origin. Of the 43,817 BRCA1/2 PSV carriers in the CIMBA database, 469 (1%) were of African descent. Additional African descent individuals were identified in public databases (n = 291) and the literature (n = 601). We identified 164 unique BRCA1 and 173 unique BRCA2 PSVs in individuals of African ancestry. Of these, 83 BRCA1 and 91 BRCA2 PSVs are of likely or possible African origin. We observed numerous differences in the distribution of PSV type and function in African origin versus non-African origin PSVs. Research in populations of African ancestry with BRCA1/2 PSVs is needed to provide the information needed for clinical management and decision-making in African descent individuals worldwide.

引用

页码：1781 / 1796

页数：16

共 50 条

[41] Comprehensive Prediction of mRNA Splicing Effects of BRCA1 and BRCA2 Variants
Mucaki, Eliseos J.
Ainsworth, Peter
Rogan, Peter K.
HUMAN MUTATION, 2011, 32 (07) : 735 - 742
[42] BRCA1 and BRCA2 in breast cancer
Yang, XH
Lippman, ME
BREAST CANCER RESEARCH AND TREATMENT, 1999, 54 (01) : 1 - 10
[43] BRCA1 and BRCA2 in breast cancer
Xiaohong Yang
Marc E. Lippman
Breast Cancer Research and Treatment, 1999, 54 : 1 - 10
[44] Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status
Figueiredo, Jane C.
Brooks, Jennifer D.
Conti, David V.
Poynter, Jenny N.
Teraoka, Sharon N.
Malone, Kathleen E.
Bernstein, Leslie
Lee, Won D.
Duggan, David J.
Siniard, Ashley
Concannon, Patrick
Capanu, Marinela
Lynch, Charles F.
Olsen, Jorgen H.
Haile, Robert W.
Bernstein, Jonine L.
BREAST CANCER RESEARCH AND TREATMENT, 2011, 127 (03) : 819 - 829
[45] BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance
Eccles, D. M.
Mitchell, G.
Monteiro, A. N. A.
Schmutzler, R.
Couch, F. J.
Spurdle, A. B.
Gomez-Garcia, E. B.
ANNALS OF ONCOLOGY, 2015, 26 (10) : 2057 - 2065
[46] Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer
Zhang, Juan
Pei, Renguang
Pang, Zhiyuan
Ouyang, Tao
Li, Jinfeng
Wang, Tianfeng
Fan, Zhaoqing
Fan, Tie
Lin, Benyao
Xie, Yuntao
BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (02) : 421 - 428
[47] Comparison of Ion Personal Genome Machine Platforms for the Detection of Variants in BRCA1 and BRCA2
Hwang, Sang Mee
Lee, Ki Chan
Lee, Min Seob
Park, Kyoung Un
CANCER RESEARCH AND TREATMENT, 2018, 50 (01): : 255 - 264
[48] Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation
Finch, Amy P. M.
Lubinski, Jan
Moller, Pal
Singer, Christian F.
Karlan, Beth
Senter, Leigha
Rosen, Barry
Maehle, Lovise
Ghadirian, Parviz
Cybulski, Cezary
Huzarski, Tomasz
Eisen, Andrea
Foulkes, William D.
Kim-Sing, Charmaine
Ainsworth, Peter
Tung, Nadine
Lynch, Henry T.
Neuhausen, Susan
Metcalfe, Kelly A.
Thompson, Islay
Murphy, Joan
Sun, Ping
Narod, Steven A.
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15) : 1547 - U43
[49] The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population
Stegel, Vida
Krajc, Mateja
Zgajnar, Janez
Teugels, Erik
De Greve, Jacques
Hocevar, Marko
Novakovic, Srdjan
BMC MEDICAL GENETICS, 2011, 12
[50] Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations
Kotsopoulos, Joanne
Gronwald, Jacek
Huzarski, Tomasz
Moller, Pal
Pal, Tuya
McCuaig, Jeanna M.
Singer, Christian F.
Karlan, Beth Y.
Aeilts, Amber
Eng, Charis
Eisen, Andrea
Bordeleau, Louise
Foulkes, William D.
Tung, Nadine
Couch, Fergus J.
Fruscio, Robert
Neuhausen, Susan L.
Zakalik, Dana
Cybulski, Cezary
Metcalfe, Kelly
Olopade, Olufunmilayo I.
Sun, Ping
Lubinski, Jan
Narod, Steven A.
JAMA ONCOLOGY, 2024, 10 (04) : 484 - 492

← 1 2 3 4 5 →